Nano-sized membrane bubbles known as extracellular vesicles activate the immune system in mice and seem to render their tumours sensitive to a type of immunotherapy drug called a checkpoint inhibitor. This is according to a new study published in Cancer Immunology Research by researchers at
A team led by scientists at Scripps Research and the University of Amsterdam has achieved an important goal in virology: mapping, at high resolution, critical proteins that stud the surface of the Hepatitis C virus (HCV) and enable it to enter host cells.
Aggressive and relatively common lymphomas called diffuse large B cell lymphomas (DLBCLs) have a critical metabolic vulnerability that can be exploited to trick these cancers into starving themselves, according to a study from researchers at Weill Cornell Medicine and Cornell's Ithaca campus
A syndrome known as immunological "exhaustion" occurs when the immune system, particularly T cells, are severely weakened by cancer and severe viral infections. Overcoming immunological exhaustion is a key goal in the development of new drugs for serious viral infections or cancer.
Security was tightened in and around Gwadar and policemen were deployed to maintain law and order in the city. According to a Pakistan newspaper, the Balochistan government has also imposed Section 144 on pillion riding and the display of weapons in Gwadar to maintain law and order.
New research published today by the University of Southampton shows new insight into how our brain develops, which can pave the way for treating neurological disorders.
A research review into molecular insights of a licorice-derived substance called glycyrrhizin for preventing or treating cancer suggests further research could lead to specific agents for clinical use.
A research team at the Cluster of Excellence Physics of Life of TU Dresden and the University of California, Santa Barbara, reveals how cells sense their mechanical environment as they build tissues during embryogenesis.
Recent pressure to maximize vaccine efficacy has stirred up many new discoveries within immunology, revealing numerous paradigms with untapped therapeutic potential.
Researchers at The University of Texas MD Anderson Cancer Center have discovered a novel immunotherapy combination, targeting checkpoints in both T cells and myeloid suppressor cells.
Neutropenia--low levels of white blood cells called neutrophils, which fight infection--develops in more than 80 per cent of patients who receive chemotherapy for blood cancer. It occurs because chemotherapy destroys neutrophils along with tumour cells.